Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options?

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 8, 2010, Pages 484-488

  Zapata, E ^a   Zubiaurre, L ^a   Castiella, A ^a   Salvador, P ^b   Garcia Bengoechea M ^b   Esandi, P ^b   Arriola, A ^b   Beguiristain, A ^c   Ruiz, I ^c   Garmendia, G ^d   Orcolaga, R ^d   Alustiza J M ^e  

^a HOSPITAL DE MENDARO   (Spain)

^b Departments of Digestive Diseases   (Spain)

^c General Surgery   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e Unidad de Osatek San Sebastián   (Spain)

Author keywords

Abdominal echography; Alpha fetoprotein; Hepatocellular carcinoma; Surveillance; Ultrasono graphy

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER THERAPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; BLOOD; EARLY DIAGNOSIS; HEALTH SURVEY; LIVER TUMOR; MIDDLE AGED; RETROSPECTIVE STUDY;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES;

EID: 78349286351     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Parkin DM. Estimating the World cancer burden: GLOBOCAN 2000. Int J Cancer 2001; 94: 153-156.
2. Colombo M, Dr Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrosis. N Engl J Med 1991; 325: 675-680.
3. Bolondi L, Sofía S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48: 251-259.
4. Llovet M. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40: 225-235.
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management on hepatocellular carcinoma. Conclusion of the Barcelona-2000. EASL conference. J Hepatol 2001; 35: 421-430.
6. Bruix J, Sherman M. Management of hepatocellular carcinoma. He-patology 2005; 42: 1208-1236.
7. Sangiovanni A, Del Ninno E, Fusoni P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with a hepatoce-llular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005-1014.
8. Wong GL, Wong VW, Tan GM, Ip KI, Lai WK, Li YW, et al. Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int 2008; 28: 79-87.
9. Tanaka H, Nouso K, Kobashi H, Kobayashi Y, Nakamura S, Ohnishi Y, et al. Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival. Liver Int 2006; 26(5): 543-551.
10. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417-422.
11. Yang B, Zhang B, Xu Y, Wang W, Shen Y, Zhang A, et al. Prospective study of early detection for primary liver cancer. J Cancer Res Clin Oncol 1997; 123: 357-360.
12. Giannini E, Arzani l, Borro P, Botta F, Fasoli A, Risso D, et al. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? Hepatogastroenterology 2000; 47: 1395-1398.
13. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepa-tology 1998; 27: 273-278.
14. Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technology Assessment 2007; 11(34).
15. Pascual S, Irurzun J, Zapater P, Such J, Sempere L, Carnicer F, et al. Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice. Liver Int 2008; 682-689.